David Moller
Keine laufenden Positionen mehr
Profil
David E.
Moller formerly worked at Eli Lilly & Co., as Vice President-Endocrine & Cardiovascular Research, Merck & Co., Inc., as Vice President-Metabolic Disorders, Poxel SA, as Chief Scientific Officer & Executive VP, Harvard Medical School, as Assistant Professor, and Sigilon Therapeutics, Inc., as Chief Scientific Officer.
Dr. Moller received his undergraduate degree from Brown University and doctorate degree from the University of Cincinnati (Ohio).
Ehemalige bekannte Positionen von David Moller
| Unternehmen | Position | Ende |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| POXEL | Chief Tech/Sci/R&D Officer | - |
Ausbildung von David Moller
| Brown University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| POXEL | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
